Natera, Inc. (NTRA) Announces Results From the SINERGY Trial [Yahoo! Finance]
Natera, Inc. (NTRA)
Last natera, inc. earnings: 2/26 04:10 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.natera.com
Company Research
Source: Yahoo! Finance
Natera, Inc. (NASDAQ: NTRA ) is one of the best strong buy healthcare stocks to invest in . On February 24, Natera, Inc. (NASDAQ:NTRA) announced results from the SINERGY trial, a Phase 2 study in recurrent or metastatic head and neck squamous cell carcinoma, with the data recently presented in an oral plenary at the 2026 MHNCS. Management reported that 27 patients received initial treatment of either immunotherapy alone or in combination with chemotherapy in the trial, and based on Signatera ctDNA dynamics during treatment, chemotherapy was either escalated or de-escalated. Natera, Inc. (NTRA): Among Stocks with Buy Ratings that Hedge Funds Love The study met its primary endpoint and showed that 74% of patients were de-escalated from chemo-immunotherapy to immunotherapy alone, which resulted in a median of 2 chemotherapy cycles across the full cohort and reflects a notable two-thirds reduction from the current standard of care. Natera, Inc. (NASDAQ:NTRA) further reported that the
Show less
Read more
Impact Snapshot
Event Time:
NTRA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NTRA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NTRA alerts
High impacting Natera, Inc. news events
Weekly update
A roundup of the hottest topics
NTRA
News
- Natera (NTRA) had its price target lowered by Morgan Stanley from $265.00 to $250.00. They now have an "overweight" rating on the stock.MarketBeat
- Natera Q4 Earnings Call Highlights [Yahoo! Finance]Yahoo! Finance
- Natera (NTRA) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates [Yahoo! Finance]Yahoo! Finance
- Natera (NTRA) had its price target raised by Wells Fargo & Company from $205.00 to $215.00. They now have an "equal weight" rating on the stock.MarketBeat
- Signatera™ MRD Data at ASCO GU Highlights Potential Utility Across GU Cancers, Including for Bladder PreservationBusiness Wire
NTRA
Earnings
- 2/26/26 - Miss
NTRA
Sec Filings
- 3/3/26 - Form 4
- 3/3/26 - Form 4
- 3/3/26 - Form 4
- NTRA's page on the SEC website